Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network
暂无分享，去创建一个
M. Papotti | M. Brizzi | L. Dogliotti | O. Bertetto | L. Ciuffreda | D. Perroni | M. Volante | A. Ferrero | A. Berruti | O. Alabiso | F. Castiglione | N. Birocco | B. Ferretti | E. Milanesi | S. Bombaci